greatest potential impact,0.37476
Management Holdings LLC.,0.332006
price target,0.201535
quarterly earnings results,-0.262873
Raptor Pharmaceutical Corp.,0.0583577
stock,-0.25337
Cornerstone Capital Management,0.332006
clinical development,0.291437
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.464711
research report,0.201535
nephropathic cystinosis,0.331552
market perform rating,0.201535
sell rating,0.409776
Zacks Investment Research,0.40995
personal trading style,0.598412
PROCYSBI delayed-release capsules,0.371668
average rating,-0.612535
Investment Management Inc.,0.365213
Capital Management Holdings,0.332006
average price,0.218034
new treatment options,0.767042
shares,0.354606
concise daily summary,0.446535
average target price,-0.612535
Asset Management L.P.,0.32558
company,-0.377394
Schwab Charles Investment,0.365213
potentially thrombotic disorder,-0.811622
Charles Investment Management,0.365213
research analyst,0.409776
drug targeting platforms,0.767042
